DocWire News Editors

DocwireNews

Georgia Tech researchers have recently developed a nanoparticle that allows physicians to detect transplanted organ rejection with a simple urine test. The nanoparticles build up in these transplanted organs and release fluorescent molecules that alter the host&rsquo;s urine appearance if rejection occurs. This process of detecting organ rejection with a urine test could potentially replace the need for invasive biopsy samples.One issue with current means of detecting organ rejection is that the transplanted organ often has suffered serious damage by the time a biopsy reveals the rejection. Additionally, organ biopsies are invasive, prone to risk, and in some cases incapable of detecting early-stage immune rejection.<a href="https://proddocwire.wpengine.com/allergy-and-immunology/nanoparticles-and-innate-immunity-new-perspectives-on-host-defence/">READ MORE:&nbsp;Nanoparticles and innate immunity: new perspectives on host defence</a>&ldquo;The biopsy is not predictive. It&rsquo;s a static snapshot. It&rsquo;s like looking at a photo of people in mid-jump,&rdquo; said Gabe Kwong, co-principal investigator in the study and an assistant professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. &ldquo;You don&rsquo;t know if they&rsquo;re on their way up or on their way down. With a biopsy, you don&rsquo;t know whether rejection is progressing or regressing.&rdquo;In early stages of rejection when a patient may feel fine, a biopsy could provide no indication of organ rejection when T cells have already started to attack the organ. The nanoparticle tested by these researchers, however, detects an enzyme called granzyme B. This enzyme drives the transplanted tissue cells into a programmed cell death known as apoptosis.The researchers note that by detecting this enzyme linked to organ degradation early on, their nanoparticle technique sets itself apart from traditional biopsy methods. &ldquo;Before any organ damage can happen, T cells have to produce granzyme B, which is why this is an early detection method,&rdquo; said Kwong.<a href="https://proddocwire.wpengine.com/future-of-medicine/iqcast-helps-diabetics-predict-blood-sugar-drops-4-hours-in-advance/">READ MORE:&nbsp;IQcast Helps Diabetics Predict Blood Sugar Drops 4 Hours in Advance</a>The researcher&rsquo;s findings come from a study conducted in a mouse model, recently published in <a href="https://www.nature.com/articles/s41551-019-0358-7">Nature Biomedical Engineering</a> this past week. Their research was funded by the National Institutes of Health, the National Science Foundation, and the Burroughs Wellcome Fund.&ldquo;This is sensitive enough to possibly detect budding rejection before you see significant injury to the transplanted organ and that could help clinicians treat early to prevent damage,&rdquo; explained Dr. Andrew Adams, co-principal investigator and an associate professor of surgery at Emory University School of Medicine. &ldquo;Right now, most tests are aimed at organ dysfunction, and sometimes they don&rsquo;t signal there is a problem until organ function is below 50 percent.&rdquo;These nanoparticles are created with iron oxide at the center and a double-coating of dextran and polyethylene glycol on the outside to keep the body from degrading it too quickly. Amino acid bristles stick out from the iron ball with fluorescent molecules attached to their tips.These particles are injected intravenously and are too large to accumulate in native tissues or be excreted through the kidneys. The nanoparticles have been engineered to still be small enough to accumulate in the tissue of transplanted organs, where they are sent to detect rejection.<a href="https://proddocwire.wpengine.com/docwire-pick/future-of-medicine-picks/crispr-patent-dispute-finally-comes-to-end-after-years/">READ MORE:&nbsp;CRISPR Patent Dispute Finally Comes to End After Years</a>Once the T cells begin to secrete the granzyme B, amino acid degradation occurs in the transplanted organ&rsquo;s cells, ultimately leading to cell death. The amino acids engineered in the nanoparticle mimic these target amino acids in the tissue, and are cut by the enzyme at the same time it attacks the foreign organ. Once these amino acids are cleaved, they release the tiny reporter molecules that go on to make the urine fluoresce.In their experiment, the researchers noted that the animals&rsquo; urine glowed and was visible in the bladder via near-infrared images.The team plans to alter their technique to detect attacks by antibodies, rather than T cells, in transplant rejection. &ldquo;Antibodies kill their target cells through similar types of enzymes. In the future, we envision a single sensor to detect both types of rejection,&rdquo; Kwong said.&ldquo;This method could be adapted to tease out multiple problems like rejection, infection or injury to the transplanted organ,&rdquo; said Adams. &ldquo;The treatments for all of those are different, so we could select the proper treatment or combination of treatments and also use the test to measure how effective treatment is.&rdquo;<blockquote class="twitter-tweet" data-lang="en">
Nanoparticles Highlight Organ Transplant Rejection Through Fluorescent Urine: Researchers at Georgia Tech have developed a sophisticated nanoparticle that can alert clinicians to the early stages of transplanted organ immune rejection&hellip; <a href="https://t.co/rLAcAYr1c4">https://t.co/rLAcAYr1c4</a> <a href="https://twitter.com/Medgadget?ref_src=twsrc%5Etfw">@medgadget</a> <a href="https://twitter.com/medtech?ref_src=twsrc%5Etfw">@medtech</a> <a href="https://t.co/64HBPqjBhm">pic.twitter.com/64HBPqjBhm</a>
&mdash; MESH&trade; Incubator at Massachusetts General Hospital (@meshincubator) <a href="https://twitter.com/meshincubator/status/1099009442119540737?ref_src=twsrc%5Etfw">February 22, 2019</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Sources: <a href="https://www.medgadget.com/2019/02/nanoparticles-highlight-organ-transplant-rejection-through-fluorescent-urine.html">Medgadget</a>, <a href="http://www.rh.gatech.edu/news/618115/urine-test-detects-organ-transplant-rejection-could-replace-needle-biopsies">Georgia Tech</a>,

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

Urine Test Detecting Organ Rejection Could Replace Invasive Biopsies

Future of Medicine

Georgia Tech researchers have recently developed a nanoparticle that allows physicians to detect transplanted organ rejection with a simple urine test. The nanoparticles build ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe